Absolute immature platelet count may predict imminent platelet recovery in thrombocytopenic children following chemotherapy

Pediatric Blood and Cancer

Volumn 60, Issue 7, 2013, Pages 1198-1203

  Have, Laerke Walther Junggreen ^a   Hasle, Henrik ^a   Vestergaard, Else Marie ^a   Kjaersgaard, Mimi ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Absolute immature platelet count (AIPC); Immature platelet fraction (IPF); Platelet transfusion; Sysmex XE 2100; Thrombocytopenia

Indexed keywords

ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN;

ABSOLUTE IMMATURE PLATELET COUNT; ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED THROMBOCYTOPENIA; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; IMMATURE PLATELET FRACTION; IMMATURE THROMBOCYTE; INFANT; LYMPHOMA; MALE; NEWBORN; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SOLID TUMOR; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEOPLASMS; PLATELET COUNT; THROMBOCYTOPENIA;

EID: 84878256535     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24484     Document Type: Article

References (23)

1. Wandt H, Schaefer-Eckart K, Frank M, et al. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2006;37:387-392.
2. Benjamin RJ, Anderson KC. What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia? Crit Rev Oncol Hematol 2002;42:163-171.
3. Buchanan GR. Blood transfusions in children with cancer and hematologic disorders: Why, when, and how? Pediatr Blood Cancer 2005;44:114-116.
4. Levin MD, van der Holt B, de Veld JC, et al. The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients. Vox Sang 2004;87:291-298.
5. Stroncek DF, Rebulla P. Platelet transfusions. Lancet 2007;370:427-438.
6. Slichter SJ, Davis K, Enright H, et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005;105:4106-4114.
7. Heal JM, Blumberg N. Optimizing platelet transfusion therapy. Blood Rev 2004;18:149-165.
8. Ingram M, Coopersmith A. Reticulated platelets following acute blood loss. Br J Haematol 1969;17:225-229.
9. Balduini CL, Noris P, Spedini P, et al. Relationship between size and thiazole orange fluorescence of platelets in patients undergoing high-dose chemotherapy. Br J Haematol 1999;106:202-207.
10. Ault KA, Rinder HM, Mitchell J, et al. The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. Am J Clin Pathol 1992;98:637-646.
11. Abe Y, Wada H, Tomatsu H, et al. A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res 2006;118:463-469.
12. Briggs C, Hart D, Kunka S, et al. Immature platelet fraction measurement: A future guide to platelet transfusion requirement after haematopoietic stem cell transplantation. Transfus Med 2006;16:101-119.
13. Takami A, Shibayama M, Orito M, et al. Immature platelet fraction for prediction of platelet engraftment after allogeneic stem cell transplantation. Bone Marrow Transplant 2007;39:501-507.
14. Yamaoka G, Kubota Y, Nomura T, et al. The immature platelet fraction is a useful marker for predicting the timing of platelet recovery in patients with cancer after chemotherapy and hematopoietic stem cell transplantation. Int J Lab Hematol 2010;32:e208-e216.
15. Kickler TS, Oguni S, Borowitz MJ. A clinical evaluation of high fluorescent platelet fraction percentage in thrombocytopenia. Am J Clin Pathol 2006;125:282-287.
16. Saigo K, Sakota Y, Masuda Y, et al. Automatic detection of immature platelets for decision making regarding platelet transfusion indications for pediatric patients. Transfus Apher Sci 2008;38:127-132.
17. Zucker ML, Murphy CA, Rachel JM, et al. Immature platelet fraction as a predictor of platelet recovery following hematopoietic progenitor cell transplantation. Lab Hematol 2006;12:125-130.
18. Chaoui D, Chakroun T, Robert F, et al. Reticulated platelets: A reliable measure to reduce prophylactic platelet transfusions after intensive chemotherapy. Transfusion 2005;45:766-772.
19. Strauss G, Vollert C, von Stackelberg A, et al. Immature platelet count: A simple parameter for distinguishing thrombocytopenia in pediatric acute lymphocytic leukemia from immune thrombocytopenia. Pediatr Blood Cancer 2011;57:641-647.
20. Fielder PJ, Gurney AL, Stefanich E, et al. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood 1996;87:2154-2161.
21. Moller P, Andersson PO, Andersson AC, et al. Plasma thrombopoietin concentrations in response to platelet transfusion therapy. Acta Haematol 2000;102:131-134.
22. Di Mario A, Garzia M, Leone F, et al. Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection. J Infect 2009;59:201-206.
23. Stohlawetz P, Folman CC, von dem Borne AE, et al. Effects of endotoxemia on thrombopoiesis in men. Thromb Haemost 1999;81:613-617.